Evidence map›Paper›PMID 29678865›Full record

SynthesisDiabetes care2018

Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis.

Teryl K Nuckols, Emmett Keeler, Laura J Anderson, Jonas Green, Sally C Morton, Brian J Doyle, Kanaka Shetty, Aziza Arifkhanova, Marika Booth, Roberta Shanman and 1 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Diabetes care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Saudi journal of biological sciences · 2021
    Article
  9. Article
  10. Review
  11. Molecules (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Teryl K NuckolsCedars-Sinai Medical Center, Los Angeles, CA teryl.nuckols@cshs.org.ORCID 0000-0002-0416-1595
Emmett KeelerRAND Corp., Santa Monica, CA.
Laura J AndersonCedars-Sinai Medical Center, Los Angeles, CA.
Jonas GreenCedars-Sinai Medical Center, Los Angeles, CA.
Sally C MortonCollege of Science, Virginia Tech, Blacksburg, VA.
Brian J DoyleVA Greater Los Angeles Healthcare System, Los Angeles, CA.
Kanaka ShettyRAND Corp., Santa Monica, CA.
Aziza ArifkhanovaRAND Corp., Santa Monica, CA.
Marika BoothRAND Corp., Santa Monica, CA.
Roberta ShanmanRAND Corp., Santa Monica, CA.
Paul ShekelleRAND Corp., Santa Monica, CA.

Funding

When Is Quality Improvement Cost Saving, Cost Effective, or Not a Good Value?R01HS022644 · AHRQ · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NUCKOLS, TERYL · 2013 to 2013
$997k
AHRQ HHS R01 HS022644
6 · The paper itself

Abstract

objectiveQuality improvement (QI) interventions can improve glycemic control, but little is known about their value. We systematically reviewed economic evaluations of QI interventions for glycemic control among adults with type 1 or type 2 diabetes. RESEARCH DESIGN AND

methodsWe used English-language studies from high-income countries that evaluated organizational changes and reported program and utilization-related costs, chosen from PubMed, EconLit, Centre for Reviews and Dissemination, New York Academy of Medicine's Grey Literature Report, and WorldCat (January 2004 to August 2016). We extracted data regarding intervention, study design, change in HbA

resultsOf 3,646 records, 46 unique studies were eligible. Across 19 randomized controlled trials (RCTs), HbA

conclusionsDiverse multifaceted QI interventions that lower HbA

Indexed as

AdultBlood GlucoseCost-Benefit AnalysisDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHumansMaleQuality-Adjusted Life YearsQuality ImprovementQuality of LifeRandomized Controlled Trials as TopicRegression AnalysisBlood Glucose

Identifiers

PMID29678865
PMCPMC5911791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.